Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lilly and BioArctic sign deal to develop neurodegenerative therapy
Genprex is conducting the Acclaim-3 Phase I/II clinical trial, assessing the combination of Reqorsa and Genentech’s Tecentriq. Credit: AnnaStills / Shutterstock.com.
Genprex is conducting the Acclaim-3 Phase I/II clinical trial, assessing the combination of Reqorsa and Genentech’s Tecentriq. Credit: AnnaStills / Shutterstock.com.
